You are here

  • Home
  • Archive
  • Volume 64, Issue 10
  • EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy

Article info

Article menu
Download PDFPDF
Original article
EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy

Authors

  1. Correspondence to Dr Erik Thunnissen, Department of Pathology, VU Medical Center, De Boelelaan 1117, 1081 HV Amsterdam 1081HV, The Netherlands; e.thunnissen{at}vumc.nl
View Full Text

Citation

Thunnissen E, Bovée JVMG, Bruinsma H, et al
EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy
Journal of Clinical Pathology 2011;64:884-892.

Publication history

  • Accepted May 4, 2011
  • First published September 22, 2011.
Online issue publication 
August 10, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.